T73515 |
MC2590
|
2284460-01-9
|
99.14%
|
|
MC2590 is a potent and selective histone deacetylase (HDAC) inhibitor that inhibits HDAC1-3, -6, -8, and -10 activities, induces cell cycle arrest, and promotes ...
|
T3108 |
CUDC-101
|
1012054-59-9
|
99.12%
|
|
CUDC-101 is a potent inhibitor of HDAC, EGFR and HER2 with IC50s of 4.4, 2.4 and 15.7 nM, respectively.
|
T6233 |
Entinostat
|
209783-80-2
|
99.11%
|
|
Entinostat (MS-275) (MS-275) is an inhibitor of HDACs that inhibits HDAC1 and HDAC3 (IC50s: 0.18/0.74 μM).
|
T6286 |
RGFP966 (E-isomer)
|
1396841-57-8
|
99.1%
|
|
RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM, exhibits > 200-fold selectivity over other HDAC.
|
T10602L |
BRD 4354
|
315698-07-8
|
99.08%
|
|
BRD 4354 is an inhibitor of HDAC5 and HDAC9. For HDAC5 and HDAC9, the IC50s values are 0.85 and 1.88 μM, respectively.
|
T30579 |
BRD4097
|
1550053-19-4
|
99.08%
|
|
BRD4097, a negative control in the HDAC1/2/3/8 assay, is a selective histone deacetylase (HDAC3) inhibitor that can be used to protect b-cells and improve insuli...
|
T16936 |
SS-208
|
2245942-72-5
|
99.07%
|
|
SS-208 is a selective inhibitor of HDAC6 (IC50 = 12 nM) with anti-tumor activity. SS-208 shows selectivity over other HDAC subtypes.
|
T60616 |
MPT0G211
|
2151853-97-1
|
99.07%
|
|
MPT0G211 is a highly selective and orally active HDAC6 inhibitor (IC50=0.291 nM) that has neuroprotective effects and has shown anti-metastatic activity in human...
|
T3661 |
Citarinostat
|
1316215-12-9
|
99.06%
|
|
ACY-241, also known as Citarinostat (ACY241), is a potent, selective and orally available histone deacetylase (HDAC) inhibitor, with potential antineoplastic act...
|
T3878 |
Raddeanin A
|
89412-79-3
|
99.05%
|
|
Raddeanin A (NSC-382873) has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.
|
T60082 |
HDAC-IN-40
|
2463198-51-6
|
99.01%
|
|
HDAC-IN-40 is a potent alkoxyamide-based HDAC inhibitor with Ki of 60 nM and 30 nM for HDAC2 and HDAC6, respectively. HDAC-IN-40 had antitumor effects
|
T2383 |
Panobinostat
|
404950-80-7
|
99.01%
|
|
Panobinostat (NVP-LBH589) is a broad-spectrum HDAC inhibitor (IC50=5 nM) with oral activity and non-selectivity. Panobinostat has antitumor activity and induces ...
|
T1602 |
Valproic acid sodium salt
|
1069-66-5
|
99%
|
|
Valproic acid sodium salt (Sodium Valproate) is the sodium salt form of valproic acid with anti-epileptic activity. Valproic acid sodium salt is converted into i...
|
T6421 |
BRD73954
|
1440209-96-0
|
98.98%
|
|
BRD73954, an effective and specific HDAC inhibitor, which is with IC50 of 36 nM and 120 nM for HDAC6 and HDAC8, respectively.
|
T1516 |
Curcumin
|
458-37-7
|
98.98%
|
|
Curcumin (Natural Yellow 3) is a phenolic natural product, an inhibitor of histone acetyltransferase p300/CREB (IC50=25 μM) with specificity. Curcumin has a wide...
|
T10244 |
ACY-1083
|
1708113-43-2
|
98.97%
|
|
ACY-1083 is a selective and brain-penetrating HDAC6 inhibitor (IC50: 3 nM) and effectively reverses chemotherapy-induced peripheral neuropathy.
|
T16529 |
BEBT-908
|
1235449-52-1
|
98.96%
|
|
BEBT-908 (PI3Kα inhibitor 1) is a selective PI3Kα inhibitor (IC50 <0.1 μM). BEBT-908 also inhibits HDAC (0.1 μM≤IC50≤1 μM).
|
T6639 |
RG2833
|
1215493-56-3
|
98.93%
|
|
RG2833 (RGFP109) (RGFP109), a brain-penetrant HDAC inhibitor, is with IC50 of 60 nM and 50 nM for HDAC1 and HDAC3, respectively.
|
T5332 |
TH34
|
2196203-96-8
|
98.77%
|
|
TH34 is an HDAC6/8/10 inhibitor (IC50s: 4.6/1.9/7.7 μM). It shows high selectivity over HDAC1/2/3.
|
T7664 |
Pyroxamide
|
382180-17-8
|
98.77%
|
|
Pyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).
|